Department of Medicinal Chemistry Seminars
SPRING 2012 Medicinal Chemistry Seminar Series
In TCRC 2066 at 11 am - 12 noon on Tuesdays,
except as noted
Date |
Lecturer |
Affiliation |
Title |
January 24 |
NO SEMINAR SCHEDULED |
||
January 31 |
WELCOME BACK/ORGANIZATIONAL MEETING |
||
February 7 |
UM MedChem |
Lysine Demethylase Inhibitors |
|
February 14 |
NO SEMINAR SCHEDULED |
||
February 21 |
Eric Bow |
UM MedChem |
Orexin Receptors - Opportunities for drug development |
February 28 |
NO SEMINAR SCHEDULED |
||
March 6 |
NO SEMINAR SCHEDULED |
||
March 13 |
SPRING BREAK - No Seminar |
||
March 20 |
Zarana Chauhan |
UM MedChem |
Recent Advances in Mineralocorticoid Receptor Antagonists |
March 27 |
Pankaj Pandey |
UM MedChem |
Bile Acid Receptor Modulators in Metabolic Diseases |
March 28, Wednesday |
Marshall Fisher |
Methamphetamine |
|
April 3 |
Catholic University of Louvain, Brussels Belgium, Faculty of Pharmacy and Biomedical Sciences and Louvain Drug Research Institute |
Squalene-drug conjugate based nanoparticles: How medicinal chemistry can help design supramolecular architectures |
|
April 10 |
Professor and Director, Center for Alcohol and Drug Abuse, and a Wilbur Mills Endowed Chair in Alcohol and Drug Abuse Prevention, Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences |
RONALD F. BORNE LECTURE Title: Therapeutic antibodies for the treatment of addiction – At the interface of chemistry and biology |
|
April 17 |
Division Director, National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH) |
2012 JOSEPH SAM DISTINGUISHED ALUMNUS Title: TBA |
|
April 24 |
TBA |
TBA |
TBA |
May 1 |
NO SEMINAR SCHEDULED |
||
Fall 2011 Medicinal Chemistry Seminar Series
Date |
Lecturer |
Affiliation |
Title |
August 23 |
MEDCHEM |
--- |
Organizational Meeting |
August 30 |
ACS DENVER NO SEMINAR |
||
September 6 |
Dr. Kip Guy |
St. Jude Children's Research Hospital
|
Screening and Synthesis of Antimalarials |
September 13 |
Shuneize Slater |
UM MedChem |
Tripeptide motifs in biology: Targets for peptidomimetic design |
September 20 CAMPUS EVENT 9AM (Ballroom,The Inn at Ole Miss) |
Dr. Roald Hoffman |
The Chemical Imagination at Work in Very Tight Places |
|
September 27 |
OPEN |
|
|
October 4 |
OPEN |
|
|
October 11 |
Dr. Robert Reynolds |
Classical NSAID Scaffolds and Chemical Biology |
|
October 18 |
OPEN |
|
|
October 25 |
AAPS MEETING |
||
November 2, Wednesday at 2pm in NPC 2066 |
Focused Studies in Heterocyclic Synthesis |
||
November 8 |
Rohit Bhat |
UM Medchem |
Dissertation Defense |
November 15 |
Walid Alsharif |
UM Medchem |
Improvement in aqueous solubility by disruption of molecular planarity and symmetry |
November 25 |
FALL BREAK |
||
November 29 |
Brian Morgan |
UM MedChem |
ORP |
Spring 2011 Medicinal Chemistry Seminar Series
In TCRC 2066, at 11 am - 12 noon on Tuesdays, except as noted
January 25 – Intro/welcome back
February 1 – Arindam Chatterjee “Saga of the third histamine receptor”
February 8 – Shuneize Slater “The Discovery and Development of 5-HT2C Receptor Agonists for the Treatment of Obesity”
February 15 – Walid Alsharif “Applications of Fluorine in Drug Discovery and Optimization”
February 22 – Cancelled
March 1 – Xiaoning Wang “Direct Renin Inhibitors as a New Therapy for Hypertension”
March 8 – Prashant V. Desai, PhD, Senior Research Scientist, Drug Disposition, Eli Lilly “Integration of In silico - In vitro - In vivo ADMET Models During Early Drug Discovery”
March 22 – Arthur S. Edison, Professor, Biochemistry & Molecular Biology, Director of Chemistry & Biology National High Magnetic Field Laboratory, University of Florida (NCNPR guest) “Chemical Ecology of Nematodes”
April 5 – Ahmed Idris “Nitrile-Containing Pharmaceuticals”
April 19 – Kate Holloway, PhD, Merck & Co., Inc. “Structure-Based Design of Protease Inhibitors”
April 21, 11am (Thursday) – Ronald F. Borne Lecture – Dr. Bruce E. Maryanoff, PhD, Department of Chemistry, The Scripps Research Institute (in TCRC 1000) “Adventures in Drug Discovery: Enzyme Inhibitors, Receptor Antagonists ... and More“
April 26 – Gregory Sawyer, PhD, Associate Professor, Department of Biochemistry and Microbiology, Center for Health Sciences, College of Osteopathic Medicine, Oklahoma State University “Muscarinic Acetylcholine Receptor Trafficking”
May 3 – Frederick T. Chin, PhD, Head of Cyclotron Radiochemistry, Molecular Imaging Program, Stanford University Medical Center
2010-2011 Borne Lecture Info:
Bruce Maryanoff has been active as a medicinal and organic chemist. He invented TOPAMAX topiramate, a unique sugar sulfamate drug, marketed worldwide for treating epilepsy and migraine, with annual sales >$2 billion. He is an internationally renown expert in drug design and discovery, esp. the application of protein structure-based drug design. Since 1991 he pursued cardiovascular therapeutics, while seeking drugs for pulmonary inflammation, metabolic disorders, and epilepsy. In the past 15 years, his drug research has dealt with structure-based drug design; peptides/peptidomimetics; enzymes inhibitors, esp. serine proteases/kinases; integrin antagonists; ligands for G-protein-coupled receptors. His efforts led to many new chemical entities entering preclinical development, with 13 advancing into human clinical trials. He made seminal contributions to understanding stereochemistry and mechanism of the Wittig reaction; devised novel peptides that self-assemble to mimic native collagen. Maryanoff is an author on 270 scientific publications, including books (Editor), book chapters, review articles. He is an inventor on 100 U.S. patents (issued/pending), presented >150 invited lectures, mentored 11 postdocs. He is Assoc. Editor of ACS Med. Chem. Lett.; organized/edited a special issue of J. Med. Chem. to honor Dr. Paul Janssen; has served on editorial advisory boards for journals and research grant committees. Maryanoff received two American Chemical Society national awards, and the prestigious Smissman Award from the Med. Chem. Division of the ACS; was inducted into the ACS Medicinal Chemistry Hall of Fame in 2008; was elected Fellow of the ACS, Amer. Assoc. for the Advancement of Science, and Royal Society of Chemistry. He retired from Johnson & Johnson in Jan 2010, after 36 years of service, and is now affiliated with The Scripps Research Institute (La Jolla, CA); Pennsylvania Drug Discovery Institute (Doylestown, PA); Institute for Hepatitis and Virus Research.
Look for the seminars to be announced in the departmental social media services (TBA) and on Ole Miss Today.
Fall 2010 Department of Medicinal Chemistry Seminar Series
Tuesdays 11 am - 12 noon (2066 NPC)
|
Date |
Speaker |
Title |
|
August |
Department of Medicinal Chemistry faculty |
Welcome and Introduction to Department |
|
August |
|
|
|
September 7 |
Khaled
Elokely |
“Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic” |
|
September 14 |
Afeef Husni |
“Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes” |
|
September 21 |
Ahmed Idris |
“The FGF family: biology, |
|
September 28 |
David
Rotella, Ph.D. |
“A Dual Target Approach for Schizophrenia”
|
|
October |
John Babu,
Ph.D. |
TBA |
|
October |
Xaoning Wang |
TBA |
|
October |
Timothy A.
Blizzard, Ph.D. |
“Overcoming bacterial resistance to beta-lactam antibiotics: A tale of two drug discovery programs.” |
|
October |
|
|
|
November 2 |
Amit
Kalgutkar, Ph.D. |
“Chemical Toxicophores: Potential for Trouble” |
|
November 9 |
|
|
|
November 16 |
NO SEMINAR |
2010 FIP Pharmaceutical Sciences World Congress/AAPS Annual Meeting; New Orleans |
|
November 23 |
NO SEMINAR |
Fall Break |
|
November 30 |
NO SEMINAR |
2010 joint meeting of the 66th Southwest and 62nd Southeastern Regional Meetings of ACS; New Orleans, LA |
